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Abstract Vacuolar sequestration or cellular extrusion of
glutathione-conjugated xenobiotics and catabolites by ATP-
binding cassette (ABC) transporters is an important detoxifica-
tion mechanism operating in many species. In this study, we show
that the yeast ABC transporter Bpt1p, a paralogue of Ycf1p,
acts as an ATP-dependent vacuolar pump for glutathione
conjugates. Bpt1p, which is inhibited by vanadate and glib-
enclamide, accounts for one third of the total vacuolar transport
of glutathione conjugates. Furthermore, immunoblot analyses
show that Bpt1p levels are strongly elevated in early stationary
phase, consistent with a function of Bpt1p in vacuolar
detoxification. ( 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Conjugation of environmental toxins as well as cellular ca-
tabolites and their subsequent elimination from the cytosol
represents an important pathway for cellular detoxi¢cation
in eukaryotic cells. Thus, covalent attachment of xenobiotics
to glutathione, glucuronide or sulfate, followed by vacuolar
sequestration of conjugates, constitutes an important mecha-
nism of detoxi¢cation, at least in plant and fungal species. The
actual membrane translocation steps are mediated by MRP-
like (multidrug resistance-related protein) transporters, a sub-
family of the ubiquitous ATP-binding cassette (ABC) trans-
porter family [1^3]. A total of four human MRPs have been
identi¢ed as epithelial glutathione conjugate pumps involved
in detoxi¢cation processes. For instance, MRP1 (ABCC1), the
major transporter for the glutathione-conjugated leukotriene
LTC4 [4], is expressed ubiquitously in humans and protects
cells and tissues by pumping conjugated xenobiotics into the
body [5]. By contrast, MRP2 (ABCC2), localized mainly at
the apical side of polarized epithelia in liver and kidney, me-
diates terminal excretion of conjugated compounds into the
bile or urine [6^8]. Finally, another human ABC protein re-
lated to MRPs is the cystic ¢brosis transmembrane conduc-
tance regulator (CFTR) [9,10]. Mutations in the CFTR chlo-
ride channel cause cystic ¢brosis, the most frequent genetic
disease in caucasians [11].
Vacuolar sequestration of conjugated compounds, heavy
metals and catabolites is also a prominent way of cellular
detoxi¢cation in plants [12]. For example, four Arabidopsis
thaliana MRPs, AtMRP1, AtMRP2, AtMRP3 and AtMRP5,
exhibit glutathione transport activity [13^16]. Furthermore,
AtMRP2 and AtMRP5 pump glucuronides [16,17], suggesting
that certain vacuolar MRPs display ATP-dependent transport
activities for arti¢cial and plant-speci¢c glucuronides [18^20].
In the yeast Saccharomyces cerevisiae, six members of the
MRP family exist [21], some of which reside in the vacuole.
Ycf1p, the cadmium resistance factor [22], represents an im-
portant mediator of cellular detoxi¢cation through vacuolar
sequestration of a wide variety of glutathione conjugates [22^
25], as well as cadmium tolerance through ATP-dependent
transport of bis(glutathionato)cadmium complexes [26]. Nota-
bly, functional expression in yeast revealed that human
MRP1, as well as plant AtMRP1, AtMRP2, AtMRP3 and
AtMRP5, can complement the organic anion transport activ-
ity of Ycf1p [13^17,24]. Because Ycf1p shares some homology
with human CFTR, it was used as a model for the character-
ization of prevalent CFTR mutations found in cystic ¢brosis
patients [27,28]. For instance, mutations in the nucleotide-
binding domains impair cadmium resistance or LTC4 trans-
port [27,28].
Two additional yeast ABC proteins have been implicated in
vacuolar transport processes. The Ybt1p/Bat1p (YLL048c)
transporter translocates taurocholate and other bile acids
across vacuolar membranes [29]. Furthermore, Bpt1p (bile
pigment transporter-1/YLL015w), the closest yeast homologue
of Ycf1p, was originally discovered as a pump mediating vac-
uolar uptake of unconjugated bile pigments and magnetic
resonance contrast agents [30,31]. However, little information
about the biochemical properties of these ABC transporters
and potential physiological substrates is available. In this
study, we report that Bpt1p, like Ycf1p, works as a vacuolar
pump for glutathione conjugates. Bpt1p function accounts for
one third of the conjugate uptake activity, and we show that
vacuolar Bpt1p levels increase when cells approach stationary
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phase. Our data demonstrate that Bpt1p and Ycf1p are the
major players for vacuolar sequestration of glutathione con-
jugates in yeast.
2. Materials and methods
2.1. Yeast strains and plasmid constructions
Unless otherwise indicated, all yeast strains were cultivated at 30‡C.
The isogenic yeast strains DTY7 (MATK ura3-52 leu2-3,112 his6),
DTY168 (vycf1 : :hisG), YMK1 (vbpt1 : :LEU2) and YMK2 (vycf1 : :
hisG vbpt1 : :LEU2) were used for uptake experiments. YMK1 and
YMK2 were obtained by integrating a DNA fragment containing
the regions 3520 to +18 and +4032 to +4524 of YLL015w along
with the LEU2 marker into the strains DTY7 and DTY168, respec-
tively. Heavy metal resistance assays were carried out in strain W303-
1A (MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 can1-100) and
its isogenic derivatives YHW11 (vycf1 : :HIS3), YYA2 (vbpt1 : :loxP-
kanMx-loxP) and YYA3 (vbpt1 : :loxP-kanMx-loxP vycf1 : :HIS3).
The strains YYA2, YYA3 and YHW11 contained start-to-stop
vbpt1 and vycf1 deletions, respectively, generated by genomic integra-
tion of appropriate PCR products from the plasmids pFA6a-His3Mx6
[32] or pUG6 [33]. Strain YYA1 (W303-1A, BPT1 : :3HA-KanMx6)
was obtained by genomic tagging of BPT1 with the triple Haemophi-
lus in£uenzae (HA) epitope using the plasmid pFA6a-3HA-KanMx6
[34] and appropriate oligonucleotides to amplify the BPT1-HA PCR
fragment. Strain YYA9 (BPT1 : :GFP-His3Mx6) was obtained by ge-
nomic integration of a PCR product generated from plasmid pFA6a-
GFPS65T-His3Mx6 [34] into YYA1, thereby replacing the HA tag by
green £uorescent protein (GFP). All PCR products were transformed
into yeast cells by routine laboratory methods [35], and correct ge-
nomic integration was veri¢ed by PCR analysis. For construction of
the high-copy plasmid pMK1, the entire BPT1 gene (YLL015w) was
PCR-ampli¢ed from genomic DNA using appropriate oligonucleoti-
des and the Expand high ¢delity PCR system (Roche, Switzerland).
The BPT1 gene was then recloned as a NotI restriction fragment into
the corresponding site of pNEV, placing BPT1 expression under the
control of the plasma membrane ATPase promoter [36].
2.2. Yeast cell extracts, £uorescence studies and cytotoxicity assays
About 5^10 OD600 cell equivalents were harvested, washed once
and resuspended in ice-cold water. Cell extracts for SDS^PAGE anal-
ysis and immunoblotting were prepared exactly as described previ-
ously [37]. For £uorescence analysis, cells were cultured to the expo-
nential growth phase in YPD containing additional adenine to prevent
staining of the vacuolar lumen. Vacuolar membranes were stained by
incubating cells with 8 WM FM4-64 £uorescent dye (Molecular
Probes, USA) for 15 min at 30‡C. Cells were inspected on a DMR
confocal microscope (Leica Microsystems, Germany) using a Leica
TCS 4D operating system equipped with a £uorescein isothiocyanate
(FITC) and tetramethylrhodamine isothiocyanate (TRITC) ¢lter set
to detect GFP or FM4-64, respectively. Digital images were pseudo-
colored using Adobe Photoshop 6.0 (Mountain View, USA), with red
attributed to FM4-64 and green to GFP.
2.3. Preparation of yeast membrane vesicles and transport studies in
vitro
Yeast membrane vesicles for in vitro transport studies were essen-
tially isolated as described elsewhere [24,38] using the following mod-
i¢cations. Brie£y, strains DTY7, DTY168, YMK1 and YMK2 were
grown overnight in YPD to an OD600 of 2^5. YMK2 transformed
with pMK1 or the control vector pNEV were grown overnight in
selective medium to an OD600 of 1^2, washed once with water, resus-
pended in YPD and incubated for an additional 2 h. Cells were
washed twice with water and resuspended to an OD600 of 1^2 in
lyticase bu¡er (1.1 M sorbitol, 20 mM Tris^HCl pH 7.6, 1 mM di-
thiothreitol (DTT)) containing 57 units of lyticase per ml. After di-
gestion was completed, spheroblasts were collected by a 10 min cen-
trifugation at 1200Ug. Cell lysis was achieved on ice in 25 ml of
breaking bu¡er (1.1 M glycerol, 50 mM Tris^ascorbate pH 7.4,
5 mM EDTA, 1 mM DTT, 1.5% polyvinylpyrrolidone, 2 mg/ml bo-
vine serum albumin (BSA), 1 mM phenylmethylsulfonyl £uoride
(PMSF), 1 Wg/ml leupeptin), using a Dounce homogenizer and 40
strokes with a tight-¢tting glass piston. Unbroken cells and debris
were removed by washing and two centrifugations at 4000Ug for
10 min. The supernatants were pooled and spun at 100 000Ug for
45 min. The microsomal membrane pellet was suspended to an
OD600 of about 4 in vesicle bu¡er (1.1 M glycerol, 50 mM Tris^
ascorbate pH 7.4, 1 mM EDTA, 1 mM DTT, 2 mg/ml BSA, 1 mM
PMSF, 1 Wg/ml leupeptin). Small aliquots were immediately used for
transport assays or stored at 380‡C until use.
[14C]S-2,4-Dinitrobenzeneglutathione ([14C]DNB-GS; 10 mCi/
mmol) was prepared exactly as described previously [39]. Uptake of
[14C]DNB-GS into membrane vesicles was measured by the rapid
¢ltration technique using nitrocellulose ¢lters (0.45 Wm pore size;
Schleicher and Schuell). Vesicles were mixed with six parts of trans-
port bu¡er (0.4 M glycerol, 100 mM KCl, 20 mM Tris^MES pH 7.4,
1 mM DTT) and incubated with 40 WM [14C]DNB-GS at 25‡C in the
absence or presence of 5 mM Mg-ATP, unless stated otherwise. Fil-
ters were washed, dried and then subjected to liquid scintillation
counting. Counts were corrected for background and quenching.
Quanti¢cation and calculations were done using Sigma Plot (Jandel
Scienti¢c, USA).
3. Results
3.1. Bpt1p localizes to the vacuolar membrane
A previous study characterized Bpt1p (YLL015w) as a
transporter mediating uptake of unconjugated bilirubins into
vacuolar vesicles [30], implying vacuolar localization of Bpt1p.
To prove this assumption, we produced strain YYA9 express-
ing a functional Bpt1p-GFP fusion protein at chromosomal
levels. Wild type W303-1A and YYA9 cells were cultivated to
the exponential growth phase, and aliquots of cultures were
treated for 15 min with FM4-64 to stain vacuolar membranes.
After 90 min of growth in YPD lacking the dye, inspection of
W303-1A and YYA9 cells by confocal microscopy revealed a
perfect co-localization of Bpt1p-GFP and the FM4-64 £uo-
rescence signals (Fig. 1A^C) in YYA9 cells, while W303-1A
control cells lacked any detectable GFP £uorescence signals
Fig. 1. Bpt1p is a vacuolar membrane protein. Strain YYA9
(Bpt1p-GFP) was cultivated in YPD to the exponential growth
phase. Vacuolar membranes were stained in vivo by adding FM4-64
to the growth medium for 15 min as stated in Section 2. Fluores-
cence in living cells was visualized in a confocal microscope using
FITC and TRITC ¢lter sets. A: GFP £uorescence. B: FM4-64
staining of the vacuolar membrane. C: Pseudo-colored and merged
images with GFP in green and FM4-64 in red. D: The correspond-
ing transmitted light image. Bar= 5 Wm.
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(data not shown). Bpt1p-GFP signals in YYA9 cells were only
detected in vacuolar membranes, but not in any other cellular
membrane compartment, showing that Bpt1p is exclusively
localized in the yeast vacuole.
3.2. Bpt1p mediates ATP-dependent vacuolar uptake of
glutathione conjugates
Bpt1p is the closest homologue to Ycf1p, sharing more than
42% sequence identity with Ycf1p, a vacuolar transporter for
glutathione conjugates [23,24]. Hence, we performed in vitro
transport experiments using radiolabeled [14C]DNB-GS and
membrane vesicles prepared from wild type strain (DTY7)
and strains carrying vycf1 (DTY168), vbpt1 (YMK1) or a
vycf1 vbpt1 double deletion (YMK2). Speci¢c ATP-depen-
dent [14C]DNB-GS uptake into vesicles from wild type
DTY7 cells was set as 100% and compared to the transport
in vesicles isolated from isogenic deletion strains (Table 1). As
expected, vycf1 vesicles displayed a DNB-GS uptake that was
reduced by about 75% when compared to wild type cells.
Vesicles prepared from the vbpt1 deletion strain showed a
consistent reduction of DNB-GS transport by about 30%
when compared to control cells (Table 1). However, DNB-
GS uptake was essentially abolished in vesicles from the
vycf1 vbpt1 deletion strain. These data show that Bpt1p
and Ycf1p are both transporters of glutathione conjugates
and mediate the bulk of total DNB-GS uptake into vacuoles
(Table 1).
To con¢rm that Bpt1p mediates DNB-GS transport, we
overexpressed Bpt1p in the vycf1 vbpt1 strain YMK2 using
the high-copy plasmid pMK1. Membrane vesicles were pre-
pared from transformants and used to determine DNB-GS
uptake activities (Fig. 2). Vesicles from cells carrying pMK1
accumulated signi¢cant levels of [14C]DNB-GS only in the
presence of ATP, whereas vesicles from cells harboring the
empty vector control displayed only insigni¢cant DNB-GS
uptake (Fig. 2). Therefore, Bpt1p expressed from a multicopy
plasmid can restore ATP-dependent glutathione conjugate
transport in vycf1 vbpt1 cells.
To analyze the properties of Bpt1p-mediated conjugate
transport, we also investigated the e¡ects of trinucleotides, a
non-hydrolyzable ATP analogue and di¡erent inhibitors (Ta-
ble 2) on Bpt1p transport into vesicles from the strain YMK2
containing pMK1. As for Ycf1p [40], GTP can partially re-
place ATP as the energy source, since it could restore 70% of
the ATP-dependent uptake. As expected, the non-hydrolyz-
able ATP analogue adenosine 5P-(L,Q-imino)triphosphate
(AMP-PNP) failed to signi¢cantly drive DNB-GS transport
Fig. 2. Bpt1p mediates vacuolar sequestration of DNB-GS. Time-de-
pendent uptake of [14C]DNB-GS mediated by Bpt1p expressed from
the multicopy plasmid pMK1. Total membrane vesicles isolated
from YMK2 transformed with plasmid pMK1 (b) or the empty
vector (F) were incubated with 40 WM [14C]DNB-GS in the presence
(¢lled symbols) or absence (open symbols) of 5 mM Mg-ATP. All
experiments were carried out in triplicate. Error bars indicate stan-
dard deviations.
Table 1
Bpt1p and Ycf1p mediate ATP-dependent vacuolar transport of
DNB-GS
Strain pmol DNB-
GSU(minUmg
protein)1
% of wild
type activity
DTY7 (wild type) 339U 93 100.0
DTY168 (vycf1) 85U 63 25.0
YMK1 (vbpt1) 236U 9 69.7
YMK2 (vycf1 vbpt1) 2U 2 5.2
Uptake of 40 WM [14C]DNB-GS into membrane vesicles isolated
from strains DTY7, DTY168, YMK1 and YMK2 was measured in
the presence of 5 mM ATP. Incubations were terminated after 7
min and aliquots removed for liquid scintillation counting. Values
were corrected for the radioactivity bound to the ¢lters after 30 s of
uptake. Corresponding control assays were performed in the absence
of ATP. The data correspond to ¢ve independent experiments, each
of which was performed in triplicate.
Fig. 3. Bpt1p levels increase in cells approaching early stationary
phase. Immunoblotting of cellular extracts from wild type (WT) and
strain YYA1 expressing genomic levels of Bpt1p-HA in exponen-
tially growing cells (Log) and in early stationary phase cultures
(Stat). Cells were exposed to 100 WM cadmium or 5 WM CDNB for
various time periods. Extracts were subjected to immunoblotting us-
ing the monoclonal HA antibody 16B12. Lc, loading control.
Table 2
E¡ect of nucleotides and inhibitors on Bpt1p-mediated [14C]DNB-
GS transport
Nucleotide Inhibitor % of activity
ATP ^ 100
GTP ^ 70.7U 3.2
AMP-PNP ^ 12.9U 2.2
ATP 1 mM vanadate 33.7U 1.4
ATP 0.1 WM ba¢lomycin A1 100.2U 0.9
ATP 5 mM NH4Cl 87.9U 12.7
ATP 150 WM glibenclamide 19.5U 6.2
Membrane vesicles isolated from strain YMK2 harboring pMK1
were incubated for 7 min with 40 WM [14C]DNB-GS in the presence
or absence of 5 mM Mg-ATP, Mg-GTP, Mg-AMP-PNP and the
compounds indicated. Values were corrected for unspeci¢c binding
and controls were performed with membrane vesicles isolated from
YMK2 cells carrying the empty control vector in the presence and
absence of Mg-ATP. Each experiment was performed in triplicate.
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(Table 2). The presence of 1 mM vanadate, a known inhibitor
of the ATPase activity of ABC transporters, reduced trans-
port to about 33% of the control value, while ba¢lomycin A1
did not a¡ect [14C]DNB-GS uptake. Finally, ammonium chlo-
ride slightly decreased [14C]DNB-GS transport to about 88%
of the control value. By contrast, addition of 150 WM gliben-
clamide to the reaction e⁄ciently blocked 80% of the ATP-
dependent uptake.
3.3. Bpt1p levels increase when cells approach stationary phase
We have demonstrated that Bpt1p and Ycf1p share over-
lapping functions in vacuolar sequestration. Expression of
YCF1 is regulated by the stress mediator Yap1p and induced
by substrates such as cadmium. Thus, we tested whether or
not expression of BPT1 mRNA or Bpt1p protein levels are
regulated by exposure to cadmium and 1-chloro-2,4-dinitro-
benzene (CDNB) or during various growth stages. Cells ex-
pressing epitope-tagged BPT1-HA were thus grown to the
mid-exponential (OD600 of 1.0) and early stationary growth
phase (OD600 of about 8.0). Exponentially growing cells were
exposed to 100 WM cadmium and 5 WM CDNB for various
times as indicated. Extracts were subjected to immunoblotting
using the monoclonal HA antibody 16B12. Bpt1p-HA mi-
grated as an apparent double band, particularly in stationary
phase cells, which could re£ect either processing intermediates
or post-translational modi¢cations. However, Bpt1p-HA lev-
els were not in£uenced by either cadmium or CDNB (Fig. 3,
lanes 4^9), as were mRNA levels (data not shown). Never-
theless, Bpt1p levels increased more than ¢ve-fold when cells
approached early stationary phase when compared to loga-
rithmically growing cells (Fig. 3, lanes 2 and 3), whereas the
internal loading control, a cross-reaction to the HA antibody,
remained unchanged. Hence, Bpt1p levels increase sharply
when cells enter early stationary phase, which is consistent
with an important role for Bpt1p in vacuolar detoxi¢cation.
4. Discussion
In yeast only one ABC transporter, Ycf1p, was hitherto
known to act as a glutathione conjugate pump. However,
vycf1 cells still display residual vacuolar uptake activities
for conjugates. In this study, we demonstrate that the Ycf1p
homologue Bpt1p functions as the second MRP-like ABC
pump in the yeast vacuolar membrane. Bpt1p shares 42% se-
quence identity with Ycf1p, and displays a functional overlap
with Ycf1p with respect to glutathione conjugate sequestra-
tion. This conclusion is based on several observations. First,
we show here that the Bpt1p transport speci¢city includes
glutathione conjugates, many of which may arise from metab-
olism or stress as physiological substrates. Second, microscop-
ic imaging of live cells demonstrates that chromosomal levels
of Bpt1-GFP, like Ycf1p, localize exclusively to the vacuolar
membrane (Fig. 1). Third, Bpt1p comprises almost one third
of the total vacuolar uptake of glutathione conjugates into
membrane vesicles in vitro (Fig. 2, Table 1). Fourth, conju-
gate transport by Bpt1p is ATP-dependent and can be inhib-
ited by vanadate and glibenclamide (Table 2). Finally, cells
lacking Bpt1p exhibit reduced growth on medium containing
Cd2þ ions (data not shown).
Ycf1p was ¢rst identi¢ed by its ability to confer cadmium
resistance [22]. Moreover, Ycf1p-mediated heavy metal detox-
i¢cation is based on vacuolar import as glutathione complexes
[23]. We consistently observed a cadmium hypersensitivity
phenotype of vbpt1 cells, although it is much less strongly
pronounced than in the vycf1 deletion strain (data not
shown). Thus, Cd2þ transport might not represent the main
activity of Bpt1p in yeast cells in vivo. The minor role in
cadmium transport might be explained by the fact that
Bpt1p actually represents a residue-speci¢c ‘natural mutant
variant’ of Ycf1p. Residue S1212 in Ycf1p, which is essential
for cadmium resistance, is replaced by leucine in Bpt1p. Strik-
ingly, the S1212L-Ycf1p variant is very ine⁄cient in confer-
ring cadmium resistance [28]. Hence, it is not surprising that
Bpt1p has escaped discovery through genetic screens using
heavy metal resistance phenotypes.
Although Bpt1p transport activities were weaker than those
of Ycf1p with respect to heavy metal resistance and conjugate
transport, our data show that deletion of Ycf1p reduced
transport by about 75%, while Bpt1p accounted for more
than 25% of the total uptake. The reduction of DNB-GS
transport in YYA2 is a speci¢c vbpt1 phenotype, since
Bpt1p expressed from the high-copy plasmid pMK1 could
restore DNB-GS transport in a vycf1 vbpt1 background. As
expected for an ABC pump, Bpt1p-mediated transport is fu-
eled by ATP hydrolysis, although GTP can also serve as the
energy source, albeit at lower e⁄ciency. The sulfonylurea
compound glibenclamide, which has been shown to inhibit
human MRP1 [41] and AtMRP5 from A. thaliana [16], also
drastically blocks Bpt1p function in DNB-GS transport
(Table 2).
Despite an overlapping function and substrate speci¢city of
Ycf1p and Bpt1p, we present evidence for interesting di¡er-
ences concerning the regulation of these genes. YCF1 expres-
sion is tightly regulated by Yap1p in response to heavy metal
stress [26,42]. By contrast, Bpt1p expression appears not regu-
lated either by its substrates cadmium and CDNB or under
di¡erent stress conditions such as high osmolarity (data not
shown). Nevertheless, we show that Bpt1p protein levels in-
crease when cells approach early stationary phase. Hence, it is
tempting to speculate that the main Bpt1p function is to com-
bat metabolic challenges such as those yeast encounters dur-
ing high-density growth. The overlapping substrate speci¢city
of Bpt1p and Ycf1p, their identical cellular localization yet
complementary functions and distinct regulation indicate
that yeast cells are well-equipped to oppose both endogenous
and exogenous challenges such as those imposed by environ-
mental or metabolic stress.
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